Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-23 3:05 pm Unchanged | 2024-09-30 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 0 (Unchanged) | Filing History |
| 2024-10-23 2:57 pm Purchase | 2024-09-30 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 628,050 5.800% | 114,560 (+22.31%) | Filing History |
| 2024-10-23 2:44 pm Sale | 2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors Inc. | 750,000 1.030% | -641,577 (-46.10%) | Filing History |
| 2024-10-23 2:26 pm Sale | 2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors Inc. | 0 0.000% | -1,508,419 (Position Closed) | Filing History |
| 2024-10-18 2:52 pm Purchase | 2024-09-30 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 552,500 5.500% | 49,357 (+9.81%) | Filing History |
| 2024-10-18 2:21 pm Unchanged | 2024-09-30 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | Filing History |
| 2024-08-14 7:20 pm Purchase | 2024-08-06 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 686,172 (New Position) | Filing History |
| 2024-08-14 7:15 pm Purchase | 2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 6,970,425 9.900% | 2,977,839 (+74.58%) | Filing History |
| 2024-07-12 10:35 am Unchanged | 2024-06-28 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | Filing History |
| 2024-07-11 6:02 pm Unchanged | 2024-06-28 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | Filing History |
| 2024-07-11 5:52 pm Purchase | 2024-06-28 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors Inc. | 1,391,577 1.980% | 465,561 (+50.28%) | Filing History |
| 2024-07-11 5:48 pm Sale | 2024-06-28 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 7,438,181 9.900% | -21,747 (-0.29%) | Filing History |
| 2024-07-11 5:43 pm Purchase | 2024-06-28 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 513,490 7.160% | 27,500 (+5.66%) | Filing History |
| 2024-07-11 5:37 pm Unchanged | 2024-06-28 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 3,992,586 9.900% | 0 (Unchanged) | Filing History |
| 2024-05-29 3:47 pm Unchanged | 2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 464,677 9.900% | 0 (Unchanged) | Filing History |
| 2024-05-29 3:43 pm Purchase | 2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 464,677 9.900% | 464,677 (New Position) | Filing History |
| 2024-05-29 3:32 pm Purchase | 2024-05-10 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 503,143 7.750% | 200,377 (+66.18%) | Filing History |
| 2024-05-29 3:21 pm Purchase | 2024-05-13 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 7,872,489 9.900% | 7,368,228 (+1461.19%) | Filing History |
| 2024-05-17 12:58 pm Sale | 2024-04-24 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 7,459,928 9.900% | -1,528,390 (-17.00%) | Filing History |
| 2024-05-17 12:48 pm Sale | 2024-04-18 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | -188,734 (-6.39%) | Filing History |